Status:
COMPLETED
Tomotherapy Treatment for Mesothelioma
Lead Sponsor:
AHS Cancer Control Alberta
Conditions:
Mesothelioma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Mesothelioma is an incurable cancer involving the lining of the lung. Patients usually suffer progressive symptoms of shortness of breath and chest pain, until they ultimately succumb to the disease. ...
Detailed Description
Background Malignant mesothelioma of the pleura is one of the most challenging diseases to treat in oncology. It is often associated with previous exposure to asbestos many years in the past with the...
Eligibility Criteria
Inclusion
- histologic mesothelioma
- refused/ineligible for surgery or chemotherapy
- life expectancy \>3 months
Exclusion
- contraindications to thoracic radiotherapy
- unable to lie flat for duration of radiation therapy
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00469196
Start Date
October 1 2006
End Date
May 1 2015
Last Update
April 6 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T5N 2R8